tirzepatide in usa FDA approves new version of

Zepbound Blindness Lawsuit Overview Lawsuits filed against the manufacturer of Zepbound accuse the company of failing to warn users about the potential for an increased risk of blindness and other eye injuries, such as Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Wang L, Berger NA, Kaelber DC, Xu R

guilt turns a slip into a spiral, while curiosity turns a slip into data

The use of these drugs has exploded throughout industrialised countries and they have provided very significant benefits in many ways, but future discussions between a patient and their physician should include NAION as a potential risk, Joseph Rizzo, director of the Neuro-Ophthalmology Service at Mass Eye and Ear at Harvard Medical School and the studys corresponding author, said in a statement